Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Testicular Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Breast Neoplasms 1

Interventions

Therapeutics 5Flow Cytometry 4Cyclophosphamide 4Radiotherapy 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3sargramostim 2liposomal amphotericin B 2Trastuzumab 2Taxes 2Ondansetron 2Methylprednisolone 2Itraconazole 2Interleukin-12 Subunit p35 2Immunologic Techniques 2Immunoenzyme Techniques 2Etoposide 2Dexamethasone 2Caspofungin 2Carboplatin 2Calcium Dobesilate 2Busulfan 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2veliparib 1tremelimumab 1tipifarnib 1thymoglobulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Interleukin-1 × Breast × Clear all
NCT00001270 2008-03-04

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
85 enrolled
BreastGenitourinaryLymphoid

Breast Neoplasms, Lymphoma, Neoplasm Metastasis, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡